Uptake and Biodistribution of 89Zirconium-labeled Ipilimumab in Ipilimumab Treated Patients With Metastatic Melanoma
NCT03313323
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Interventions
BIOLOGICAL:
89Zirconium-labeled ipilimumab
Sponsor
Amsterdam UMC, location VUmc
Collaborators
[object Object]